Financhill
Back

Trevi Therapeutics Stock Predictions

Trevi Therapeutics Stock Forecast

  • Is Trevi Therapeutics Stock Undervalued?
    The current Trevi Therapeutics [TRVI] share price is $4.17. The Score for TRVI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • TRVI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Trevi Therapeutics Stock Go Up Next Year?

Data Unavailable

Trevi Therapeutics Stock Rating

Data Unavailable

Trevi Therapeutics Stock Price History

Is TRVI stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
trevitherapeutics.com

52-Week Data

52-Week High:
4.60
52-Week Low:
1.22

Prediction Charts

Market Cap:
320.53M
Price in USD:
4.17
Volume:
4.17M
Beta:
0.85

Technical Analysis

SMA50:
2.99
SMA100:
3.02
SMA200:
2.94
52-Wk Change:
228.35%

Stock Predictions

  • Is Trevi Therapeutics stock public?
    Yes, Trevi Therapeutics is a publicly traded company.
  • What is the Trevi Therapeutics stock quote today?
    The Trevi Therapeutics stock price is 4.17 USD today.
  • How to buy Trevi Therapeutics stock online?
    You can buy Trevi Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 2.96 2.92 3.03 2.86
Nov-26 2.90 2.88 2.93 2.83
Nov-27 2.88 2.82 2.92 2.80
Nov-29 2.85 2.88 2.93 2.80
Dec-2 2.84 2.86 2.93 2.82
Dec-3 2.84 2.78 2.86 2.74
Dec-4 2.65 2.60 2.65 2.45
Dec-5 2.61 2.60 2.63 2.49
Dec-6 2.63 2.76 2.80 2.56
Dec-9 2.76 2.66 2.86 2.57
Dec-10 2.68 2.68 2.78 2.66
Dec-11 2.73 2.49 2.73 2.36
Dec-12 3.91 3.60 4.60 3.43
Dec-13 3.95 4.17 4.28 3.75

Trevi Therapeutics Earnings

Data Unavailable

Trevi Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.00 per share.

* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.